PAVmed (Nasdaq:PAVM) announced today that it entered into a license option and joint R&D agreement with Novosound. Glasgow, Scotland-based Novosound develops proprietary flexible thin-film ultrasound technology for medical imaging. The venture-backed company currently targets next-generation intravascular ultrasound (IVUS) imaging. PAVmed … [Read more...] about Pavmed, Novosound partner on catheter-delivered ultrasound tech
Catheters
Abiomed wins FDA nod for Impella ECP pivotal heart pump trial
Abiomed (Nasdaq:ABMD) announced today that the FDA approved the version of Impella ECP for its upcoming pivotal trial. Danvers, Massachusetts-based Abiomed enrolled the first two patients in its trial following approval. Dr. Amir Kaki, director of mechanical circulatory support at Ascension St. John Hospital in Detroit, led the procedures. Get … [Read more...] about Abiomed wins FDA nod for Impella ECP pivotal heart pump trial
Boston Scientific to acquire majority stake in interventional tech developer Acotec
Boston Scientific (NYSE:BSX) announced that it intends to make a partial offer to acquire a majority stake in Acotec. Marlborough, Massachusetts-based Boston Scientific's offer could add up to a maximum of 65% of Acotec's shares. Its proposed price totals HK$20 per share. That amounts to approximately $523 million for the 65% stake at current … [Read more...] about Boston Scientific to acquire majority stake in interventional tech developer Acotec
The top 10 catheter innovation news stories of 2022
This year was a big one for catheter innovation as medtech companies large and small received regulatory approvals and researchers developed catheters that could soon make navigating the vasculature system easier. The numerous innovations weren't just limited to adults. One company launched a cryoablation catheter for children as young as 2 … [Read more...] about The top 10 catheter innovation news stories of 2022
Medtronic completes enrollment in pulsed-field ablation catheter trial
Medtronic today announced it completed enrollment and final treatment in the Sphere Per-AF pivotal trial to study Affera's pulsed-field ablation catheter tech. The trial is evaluating the safety and effectiveness of the Sphere-9. The Sphere-9 is a pulsed field (PF) and radio frequency (RF) ablation and high-density mapping catheter. Along with … [Read more...] about Medtronic completes enrollment in pulsed-field ablation catheter trial
Catheter Precision’s VIVO System treats more than 800 patients
Catheter Precision today announced that more than 800 procedures have been performed using its VIVO System in the U.S. and Europe. The VIVO (View Into Ventricular Onset) System allows physicians to noninvasively identify an area of ventricular arrhythmia onset. It uses noninvasive 3D imaging that identifies the origin of arrhythmias … [Read more...] about Catheter Precision’s VIVO System treats more than 800 patients
TriSalus releases positive data for its catheter-based drug delivery tech
TriSalus Life Sciences today announced positive clinical results for its Pressure-Enabled Regional Immuno-Oncology technology. The company, currently in the process of going public through a SPAC merger, filed a presentation for investors. It features information regarding its ongoing PERIO 01 and PERIO 02 clinical studies. The studies evaluate … [Read more...] about TriSalus releases positive data for its catheter-based drug delivery tech
Why Affera’s cardiac ablation technology is worth $1B to Medtronic
Affera started in 2014 with a simple goal that paid off when Medtronic (NYSE:MDT) bought the company for up to $1 billion this year. Achieving that goal, however, took some unconventional and sometimes difficult design choices, Affera founder and CEO Doron Harlev said. Newton, Massachusetts–based Affera's system diagnoses, maps and treats … [Read more...] about Why Affera’s cardiac ablation technology is worth $1B to Medtronic
Surmodics beats The Street in Q4 results, grows sales 8%
Surmodics (Nasdaq:SRDX) today posted fourth-quarter results that beat the overall consensus on Wall Street. The Eden Prairie, Minnesota-based IVD tech developer reported net losses of $14.7 million, or -$1.06 per share, on sales of $25.99 million for the three months ended Sept. 30, representing a sales growth of 8.41% compared to Q4 2021. The … [Read more...] about Surmodics beats The Street in Q4 results, grows sales 8%
Baylis Medical Technologies, Oscor sign distribution agreement
Baylis Medical Technologies today announced it signed a sales and distribution agreement with Oscor. Through the agreement, Boston Scientific's Baylis will distribute Oscor's steerable and guiding sheaths that are currently sold direct-to-hospital. It will allow Baylis to broaden its clinical solution offerings in radiology and vascular … [Read more...] about Baylis Medical Technologies, Oscor sign distribution agreement